Combination therapies with mitogen-activated protein kinase kinase inhibitors and immune checkpoint inhibitors in non-small cell lung cancer.

Combination therapies with mitogen-activated protein kinase kinase inhibitors and immune checkpoint inhibitors in non-small cell lung cancer. Chin Med J (Engl). 2020 Sep 15;: Authors: Xu JL, Wang XZ, Jiang HN, Chen Y, Wang R, Shu YQ PMID: 32941237 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32941237?dopt=Abstract

Source: Chinese Medical Journal - September 14, 2020 Category: General Medicine Authors: Xu JL, Wang XZ, Jiang HN, Chen Y, Wang R, Shu YQ Tags: Chin Med J (Engl) Source Type: research